心泰醫療(02291.HK):股價異動 未知悉原因
格隆匯4月22日丨心泰醫療(02291.HK)公告,董事會留意到近期公司股份在聯交所的價格及成交量的波動以及公司控股股東之一,樂普(北京)醫療器械股份有限公司(其股份於深圳證券交易所創業板上市,證券代碼:300003),於2025年4月21日發佈的投資者關係活動記錄表,當中分別提及公司的封堵器類產品預計銷售增長目標約爲30%及經導管主動脈瓣置換術產品預計銷售目標約爲人民幣2億元,其實現存在不確定性並取決於市場情況。
除以上載列的信息外,基於公司的理解,公司股份近期的價格及成交量的變動亦代表投資者對本公司業績及表現持續成長的認同及體現公司價值的迴歸,以及董事會確認其不知悉導致此價格及成交量的變動的任何其他原因或其他證券及期貨條例第XIVA部項下須披露的公司內幕消息。
公司已向聯交所申請於2025年4月23日(星期三)上午九時起恢復買賣公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.